JS Medical will be exhibiting the EMDA® drug delivery system at BAUS Brighton.
Latest data from Guy’s & St Thomas’ endorses intravesical sequential BCG/EMDA+MMC for HR-NMIBC
REMEDIAL III trial results presented at TCT2019 in San Franciso by Dr Carlo Briguori.
RenalGuard Solutions has appointed JS Medical as their new UK and Ireland distributor.
Murat Celebi is meeting innovative MedTech companies at CIRSE2019 – is international expansion in your strategy?
We are counting down to BAUS 2019 in Glasgow next week.
EuroPCR 2019 proved as informative as ever with Robin Luper delighted to share the benefits of the RenalGuard System™ with new contacts as well as catching up with colleagues.
Physion has appointed JS Consulting as their strategic advisor for the GCC & Middle East regions.
NICE has called for EMDA® to be used in research programmes as a treatment for bladder cancer.
With the first case of RenalGuard® treatment successfully undertaken in Baku, Robin Luper finds TV fame!